Skip to Content
Print Save

AN 322 (Niacin Extended-Release 750 mg)

Pill with imprint AN 322 is Orange, Capsule-shape and has been identified as Niacin Extended-Release 750 mg. It is supplied by Amneal Pharmaceuticals of New York, LLC.

Niacin is used in the treatment of high cholesterol; hyperlipoproteinemia; niacin deficiency; pellagra; hyperlipoproteinemia type iv, elevated vldl and belongs to the drug classes miscellaneous antihyperlipidemic agents, vitamins. Risk cannot be ruled out during pregnancy. Niacin 750 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for AN 322

Niacin extended-release 750 mg AN 322
Niacin extended-release 750 mg AN 322
Niacin extended-release 750 mg AN 322

Niacin Extended-Release

Imprint
AN 322
Strength
750 mg
Color
Orange
Size
19.00 mm
Shape
Capsule-shape
Availability
Rx and/or OTC
Drug Class
Miscellaneous antihyperlipidemic agents, Vitamins
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Amneal Pharmaceuticals of New York, LLC
Inactive Ingredients
FD&C Yellow No. 6, hydroxyethyl cellulose (4000 mpa.s at 1%), hypromelloses, polyethylene glycol, ferric oxide red, stearic acid, titanium dioxide, ferric oxide yellow

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
65162-0322 Amneal Pharmaceuticals LLC
10135-0613 Marlex Pharmaceuticals Inc.
More Info Imprint Search Print

Get help with Imprint Code FAQs.

Related Images for "AN 322"

Mexiletine Hydrochloride
Temozolomide

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer